Health Care (CNBC)
Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results
The results could pave the way for Pfizer's drug ponsegromab to become the first-ever approved treatment specifically for cancer cachexia.
2 days 4 hours ago
Checkout newsBoar's Head indefinitely closes Virginia plant tied to deadly listeria outbreak, discontinues liverwurst
The company called the outbreak a "dark moment" in its history and apologized for the contamination of its liverwurst product, linked to the deaths of nine people.
2 days 22 hours ago
Checkout newsFlorida discourages use of mRNA Covid vaccines in older adults
In updated guidance to health care providers, Florida health officials advise that "non-mRNA Covid-19 vaccines and treatment" should be prioritized.
2 days 22 hours ago
Checkout newsModerna shares plunge on plans to cut $1.1 billion in costs, launch 10 new products by 2027
Moderna is deprioritizing certain parts of its pipeline, which involves pausing work on some products and scrapping others.
4 days 1 hour ago
Checkout newsGilead says its twice-yearly shot cut HIV infections by 96% in trial
The data sets the stage for likely approval of Gilead's lenacapavir for HIV prevention.
4 days 1 hour ago
Checkout newsApple turning AirPods into hearing aids underscores effort to crack massive health market
Apple is using its newest AirPods Pro as a way to help break into the health industry, a potential $15 trillion market.
4 days 1 hour ago
Checkout newsEli Lilly says it will invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
Demand for Eli Lilly's Zepbound and Mounjaro has outstripped supply over the last year, forcing the company to invest heavily to increase production.
4 days 1 hour ago
Checkout newsDigital health company Noom to offer compounded GLP-1 drug through new weight loss program
Digital health company Noom is offering compounded GLP-1 drugs to patients in new weight loss program
4 days 3 hours ago
Checkout news'Economy class syndrome' is a medical issue that can happen on flights — no matter where you sit
Deep vein thrombosis can be a serious health issue that strikes at any time. But medium-to long-haul flights increase the risk of developing it.
4 days 16 hours ago
Checkout newsThis government-backed startup is growing blood to help fight shortages
Safi Biotherapeutics, a government-backed startup, is growing blood in a lab to help fight shortages.
5 days 1 hour ago
Checkout newsHealthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
A large swath of insured Americans could be eligible for a popular class of weight loss and diabetes drugs. Meanwhile, Apple announces new health features.
5 days 22 hours ago
Checkout newsAstraZeneca shares fall 5% on disappointing lung cancer drug trial results
AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical giant announced disappointing lung cancer drug trial results.
6 days 7 hours ago
Checkout newsAlzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
Leqembi's rollout has been slowed by bottlenecks related to reimbursement uncertainties, diagnostic test requirements and regular brain scans, among others.
1 week 1 day ago
Checkout newsHealthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
Eli Lilly could be on its way to topping $1 trillion in market value. Meanwhile, Abbott launches its first over-the-counter continuous glucose monitor in U.S.
1 week 3 days ago
Checkout newsAbbott launches its first over-the-counter continuous glucose monitor in the U.S.
Abbott Laboratories announced Lingo, its first over-the-counter continuous glucose monitor, is available in the U.S.
1 week 4 days ago
Checkout newsGE Healthcare shows signs of life, but a lingering uncertainty keeps us on the sidelines
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
1 week 4 days ago
Checkout newsWe're taking a nearly 300% profit on a hot drug stock — adhering to an investing rule to live by
A journey inside Epic Systems' mythical and sprawling campus, a world away from Wall Street
Epic Systems, a 45-year-old health-care software company, remains privately held with a sprawling campus that's far from Wall Street or Silicon Valley.
2 weeks 1 day ago
Checkout newsFDA authorizes Novavax’s updated Covid vaccine, paving way for fall rollout
The decision comes only a week after it approved a new round of messenger RNA shots from Pfizer and Moderna, which both target an offshoot of JN.1 called KP.2.
2 weeks 2 days ago
Checkout newsEli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
Eli Lilly is offering 2.5-milligram and 5-milligram single-dose vials of Zepbound for $399 per month and $549 per month, respectively.
2 weeks 5 days ago
Checkout newsIn 51 U.S. states are published
4087
Companies
1101
Counties
1940
Cities
The 5 newest Companies
2100 Southbridge Pkwy #640, Birmingham, AL 35209
5404 W Elm St, McHenry, IL 60050
500 Cornwall Ave, Cheshire, CT 06410
7545 Irvine Center Dr, Irvine, CA 92618
501 Commendencia St # 1, Pensacola, FL 32502
Other Companies
431 Apollo Beach Blvd, Apollo Beach, FL 33572
2240 Palm Beach Lakes Blvd #250, West Palm Beach, FL 33409
6425 Youree Dr Suite 140, Shreveport, LA 71105
120 S LaSalle St #1700, Chicago, IL 60603
195 Wekiva Springs Rd #206, Longwood, FL 32779